An Open-label, Multi-center, Long-term Extension Study of Zanubrutinib (BGB-3111) in Patients with B-cell Malignancies

Project: Research

Project Details

StatusActive
Effective start/end date13/08/2012/08/25

Keywords

  • clinical trial
  • treatment efficacy
  • lymphoma
  • leukemia
  • treatment safety